ArticleFrontiers in pharmacology2022

Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China.

Ruxu You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.